Please ensure Javascript is enabled for purposes of website accessibility
Home > Products > Antibodies > Primary antibodies

Anti-ADRA2C Recombinant Antibody (N378/107) (HB097033)

Anti-ADRA2C Recombinant Antibody (N378/107)
Anti-ADRA2C Recombinant Antibody (N378/107)
Price(USD): --
Spec:
  • 50ug
  • 100ug
  • 1mg
Number:
Get quote
  • Overview

  • Images

  • References

  • Datasheet

  • SDS

Overview
Catalog No.HB097033
Description
Anti-Alpha-2C adrenergic receptor Recombinant Antibody (N378/107) (HB097033) is a mouse monoclonal antibody detecting ADRA2C in IHC, WB.
Highlights
  • ●Affinity Purified — Minimal background and high purity for reliable results.
  • ●Multi-Application — Validated across multiple applications.
ApplicationsIHC, WB
Host speciesMouse
ClonalityMonoclonal
IsotypeIgG2a, kappa
Clone IDN378/107
Target ADRA2L2, ADRA2C, Alpha-2CAR, Alpha-2C adrenoreceptor, Alpha-2C adrenoceptor, Alpha-2C adrenergic receptor, ADRA2RL2, Alpha-2 adrenergic receptor subtype C4
Endotoxin level < 10 EU/mg as determined by LAL method.
Purity >95% as determined by SDS-PAGE.
Purification Protein A/G purified from cell culture supernatant.
RRID

Anti-Alpha-2C adrenergic receptor Antibody (N378/107) (abinScience Cat# HB097033, RRID:AB_3728150)
_x005F_x000D_

Form Liquid
Storage buffer 0.01M PBS pH 7.4.

Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.

Product Usage Information
Application Dilution
WB 1:500-1:2000
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Background

Alpha-2C adrenergic receptor (ADRA2C) is a ~49 kDa protein. Alpha-2 adrenergic receptors are G protein-coupled receptors for catecholamines that activate the G(i/o) protein pathway, thereby promoting adenylyl cyclase inhibition, ERK1/2 stimulation, and voltage-gated calcium channels suppression. Control a variety of physiological processes, such as regulation of blood pressure, lipolysis and insulin release. ADRA2A and ADRA2C mediates the presynaptic feedback inhibition of neurotransmitter release from noradrenergic nerve terminals in sympathetic and central nervous systems. ADRA2A inhibits transmitter release at high stimulation frequencies, whereas ADRA2C modulates neurotransmission at lower levels of nerve activity. The rank order of potency for physiological agonists of ADRA2C is epinephrine > norepinephrine > dopamine.

1. Regan, JW. et al. (1988) Proceedings of the National Academy of Sciences of the United States of America 85, 6301-5. PMID: 2842764
Note For research use only.
Images
  • Anti-ADRA2C Recombinant Antibody (N378/107)

    SDS-PAGE

    SDS-PAGE for Anti-Alpha-2C adrenergic receptor Antibody (N378/107)

References
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Recommendation

Contact us for custom quotes, bulk requests and any other issues.

Mail: [email protected]

Distributor list